A few decades ago, half of American women diagnosed with breast cancer died of the disease. Today fewer than one in five cases is fatal, according to Dr. Marc Lippman, a nationally recognized breast cancer researcher and professor at the University of Miami’s Miller School of Medicine. Read the rest of this entry »

Diagnostic testing to determine the use of targeted therapy is a valuable tool in helping physicians guide treatment options for patients, particularly women who have been diagnosed with breast cancer. Read the rest of this entry »

Researchers involved in a multi-center trial have reported that adding ixabepilone (Ixempra™) to Xeloda® (capecitabine) improves outcomes of patients with ER/PR/HER2-negative metastatic breast cancer (MBC) resistant to anthracyclines and taxanes. Read the rest of this entry »

According to a health researcher at McGill University, the best long-term therapy for breast cancer survivors has nothing to do with doctors or self-help books, but dragon boat racing. Read the rest of this entry »

According to an article recently published in the Journal of the National Cancer Institute, whether or not a woman with early breast cancer receives radiation therapy may be determined by certain characteristics of her surgeon. Read the rest of this entry »

IPSOGEN SAS has announced the signature of a license agreement with Universite Libre de Bruxelles (ULB), Belgium for the worldwide and exclusive rights on the Genomic Grade™.
Read the rest of this entry »

Report Buyer, the online destination for business intelligence for major industry sectors, has added a report which finds that an FDA advisory panel has said that Genentech/Roche’s Avastin® should not receive FDA approval for metastatic breast cancer.
Read the rest of this entry »

Taking a statin drug does not seem to increase or decrease the likelihood of a woman developing breast cancer, according to a study published in the medical journal Cancer. Some lab studies have shown that statins inhibit the proliferation of breast cancer cells, note Dr. Gaia Pocobelli, of the University of Washington, Seattle, and colleagues. Conversely, other studies, in which rodents were exposed to high doses of statins, showed increases in several types of cancer.

http://www.sciam.com/article.cfm?id=statins-not-seen-linked-t